Across TCGA pan-cancer cohorts, STK33P1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated STK33P1 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher STK33P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated STK33P1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.
ACC, KIRC, and LIHC are the cancer types where STK33P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.